Burning Rock Biotech (BNR) Other Operating Expenses (2019 - 2025)

Burning Rock Biotech's Other Operating Expenses history runs 7 years deep, the most recent figure standing at -$6.3 million for Q4 2025.

• In Q4 2025, Other Operating Expenses rose 43.81% year-over-year to -$6.3 million; the TTM figure through Dec 2025 stood at -$23.1 million (up 26.4% YoY), while the FY2025 annual figure was $23.3 million, down 24.79% from the prior year.
• Other Operating Expenses was -$6.3 million for Q4 2025 at Burning Rock Biotech, down from -$5.8 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of -$5.3 million in Q2 2025 to a low of -$16.2 million in Q4 2021.
• Historically, Other Operating Expenses has averaged -$9.6 million across 5 years, with a median of -$9.0 million in 2023.
• The sharpest annual moves came in 2021 and 2025: Other Operating Expenses plunged 96.95% in 2021, then surged 43.81% in 2025.
• A 5-year view of Other Operating Expenses shows it stood at -$16.2 million in 2021, then rose by 23.76% to -$12.3 million in 2022, then jumped by 43.22% to -$7.0 million in 2023, then tumbled by 59.93% to -$11.2 million in 2024, then soared by 43.81% to -$6.3 million in 2025.
• The last three Other Operating Expenses figures came in at -$6.3 million (Q4 2025), -$5.8 million (Q3 2025), and -$5.3 million (Q2 2025), per Business Quant data.